HK1055957A1 - 7-Heterocyclyl quinoline and thieno(2,3-B)pyridinederivatives useful as antagonists of gonadotropin releasing hormone - Google Patents
7-Heterocyclyl quinoline and thieno(2,3-B)pyridinederivatives useful as antagonists of gonadotropin releasing hormoneInfo
- Publication number
- HK1055957A1 HK1055957A1 HK03108228A HK03108228A HK1055957A1 HK 1055957 A1 HK1055957 A1 HK 1055957A1 HK 03108228 A HK03108228 A HK 03108228A HK 03108228 A HK03108228 A HK 03108228A HK 1055957 A1 HK1055957 A1 HK 1055957A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antagonists
- useful
- releasing hormone
- gonadotropin releasing
- pyridinederivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25482700P | 2000-12-12 | 2000-12-12 | |
| US09/992,785 US6583153B2 (en) | 2000-12-12 | 2001-11-14 | 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone |
| PCT/US2001/048119 WO2002048112A2 (en) | 2000-12-12 | 2001-12-11 | 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1055957A1 true HK1055957A1 (en) | 2004-01-30 |
Family
ID=26944257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK03108228A HK1055957A1 (en) | 2000-12-12 | 2003-11-12 | 7-Heterocyclyl quinoline and thieno(2,3-B)pyridinederivatives useful as antagonists of gonadotropin releasing hormone |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6583153B2 (es) |
| EP (2) | EP1345907B1 (es) |
| JP (1) | JP4427251B2 (es) |
| CN (1) | CN1288137C (es) |
| AT (2) | ATE450510T1 (es) |
| AU (2) | AU2903302A (es) |
| CA (1) | CA2431617C (es) |
| CY (2) | CY1105712T1 (es) |
| DE (2) | DE60140700D1 (es) |
| DK (2) | DK1520855T3 (es) |
| ES (2) | ES2269499T3 (es) |
| HK (1) | HK1055957A1 (es) |
| PT (2) | PT1345907E (es) |
| WO (1) | WO2002048112A2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6455734B1 (en) * | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| TW200413351A (en) | 2002-08-21 | 2004-08-01 | Astrazeneca Ab | Chemical compounds |
| US20040082612A1 (en) * | 2002-10-15 | 2004-04-29 | Baxter Ellen W | Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives |
| CA2631917A1 (en) * | 2005-12-05 | 2007-06-14 | Merck & Co., Inc. | Quinolone m1 receptor positive allosteric modulators |
| WO2011049731A1 (en) * | 2009-10-21 | 2011-04-28 | Merck Sharp & Dohme Corp. | Quinolinone-pyrazolone m1 receptor positive allosteric modulators |
| CN116239498B (zh) * | 2023-05-11 | 2023-07-21 | 北京元延医药科技股份有限公司 | 制备克立硼罗中间体的方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4659691A (en) | 1985-02-08 | 1987-04-21 | Merck & Co., Inc. | Novel cyclic Hexapeptide LHRH antagonists |
| US5140009A (en) | 1988-02-10 | 1992-08-18 | Tap Pharmaceuticals, Inc. | Octapeptide LHRH antagonists |
| US5171835A (en) | 1988-10-21 | 1992-12-15 | The Administrators Of The Tulane Educational Fund | LHRH antagonists |
| TW449600B (en) | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
| US5607939A (en) | 1994-04-28 | 1997-03-04 | Takeda Chemical Industries, Ltd. | Condensed heterocyclic compounds, their production and use |
| WO1995029900A1 (en) | 1994-04-29 | 1995-11-09 | Takeda Chemical Industries, Ltd. | CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS |
| CN1072219C (zh) | 1995-06-01 | 2001-10-03 | 武田药品工业株式会社 | 二氮杂䓬酮、其生产和用途 |
| CA2229205A1 (en) | 1995-10-19 | 1997-04-24 | Shuichi Furuya | Thienopyridine derivatives, their productions and use |
| DE69623655T2 (de) * | 1995-10-19 | 2003-04-24 | Takeda Chemical Industries, Ltd. | Chinolinderivate als gnrh antagonisten |
| NZ325060A (en) | 1995-12-14 | 2000-02-28 | Merck & Co Inc | Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone |
| SK77598A3 (en) | 1995-12-14 | 1999-01-11 | Merck & Co Inc | Nonpeptide derivatives, pharmaceutical composition containing them and their use |
| WO1997041126A1 (en) | 1996-04-26 | 1997-11-06 | Takeda Chemical Industries, Ltd. | Thienopyridine derivatives, their production and use |
| EP0906115A1 (en) | 1996-04-30 | 1999-04-07 | Takeda Chemical Industries, Ltd. | COMBINED USE OF GnRH AGONIST AND ANTAGONIST |
| WO1997044037A1 (en) | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| EP0901471A4 (en) | 1996-05-20 | 1999-08-25 | Merck & Co Inc | GONADOTROPIN RELEASING HORMONE ANTAGONISTS |
| AU712019B2 (en) | 1996-05-20 | 1999-10-28 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| WO1997044339A1 (en) | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| GB9610813D0 (en) | 1996-05-23 | 1996-07-31 | Pharmacia Spa | Combinatorial solid phase synthesis of a library of benzufuran derivatives |
-
2001
- 2001-11-14 US US09/992,785 patent/US6583153B2/en not_active Expired - Lifetime
- 2001-12-11 PT PT01990166T patent/PT1345907E/pt unknown
- 2001-12-11 EP EP01990166A patent/EP1345907B1/en not_active Expired - Lifetime
- 2001-12-11 DE DE60140700T patent/DE60140700D1/de not_active Expired - Lifetime
- 2001-12-11 CA CA2431617A patent/CA2431617C/en not_active Expired - Lifetime
- 2001-12-11 DE DE60122575T patent/DE60122575T2/de not_active Expired - Lifetime
- 2001-12-11 ES ES01990166T patent/ES2269499T3/es not_active Expired - Lifetime
- 2001-12-11 AU AU2903302A patent/AU2903302A/xx active Pending
- 2001-12-11 AT AT04078019T patent/ATE450510T1/de active
- 2001-12-11 DK DK04078019.9T patent/DK1520855T3/da active
- 2001-12-11 AT AT01990166T patent/ATE337303T1/de active
- 2001-12-11 ES ES04078019T patent/ES2337898T3/es not_active Expired - Lifetime
- 2001-12-11 PT PT04078019T patent/PT1520855E/pt unknown
- 2001-12-11 JP JP2002549643A patent/JP4427251B2/ja not_active Expired - Lifetime
- 2001-12-11 CN CNB018225985A patent/CN1288137C/zh not_active Expired - Lifetime
- 2001-12-11 EP EP04078019A patent/EP1520855B1/en not_active Expired - Lifetime
- 2001-12-11 DK DK01990166T patent/DK1345907T3/da active
- 2001-12-11 WO PCT/US2001/048119 patent/WO2002048112A2/en active IP Right Grant
- 2001-12-11 AU AU2002229033A patent/AU2002229033B2/en not_active Expired
-
2003
- 2003-04-03 US US10/406,393 patent/US6765011B2/en not_active Expired - Lifetime
- 2003-11-12 HK HK03108228A patent/HK1055957A1/xx not_active IP Right Cessation
-
2006
- 2006-10-18 CY CY20061101492T patent/CY1105712T1/el unknown
-
2010
- 2010-02-09 CY CY20101100121T patent/CY1110589T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE337303T1 (de) | 2006-09-15 |
| CA2431617C (en) | 2011-07-12 |
| DE60140700D1 (de) | 2010-01-14 |
| EP1345907A2 (en) | 2003-09-24 |
| EP1520855B1 (en) | 2009-12-02 |
| CN1288137C (zh) | 2006-12-06 |
| PT1345907E (pt) | 2006-11-30 |
| DE60122575T2 (de) | 2007-09-13 |
| PT1520855E (pt) | 2010-01-06 |
| US20030216429A1 (en) | 2003-11-20 |
| EP1345907B1 (en) | 2006-08-23 |
| WO2002048112A2 (en) | 2002-06-20 |
| EP1520855A1 (en) | 2005-04-06 |
| US6583153B2 (en) | 2003-06-24 |
| AU2903302A (en) | 2002-06-24 |
| US20020123506A1 (en) | 2002-09-05 |
| ATE450510T1 (de) | 2009-12-15 |
| WO2002048112A3 (en) | 2002-08-22 |
| CY1110589T1 (el) | 2015-04-29 |
| DK1520855T3 (da) | 2010-03-15 |
| JP4427251B2 (ja) | 2010-03-03 |
| AU2002229033B2 (en) | 2007-09-13 |
| CN1489579A (zh) | 2004-04-14 |
| CY1105712T1 (el) | 2010-12-22 |
| US6765011B2 (en) | 2004-07-20 |
| ES2337898T3 (es) | 2010-04-30 |
| DE60122575D1 (de) | 2006-10-05 |
| CA2431617A1 (en) | 2002-06-20 |
| ES2269499T3 (es) | 2007-04-01 |
| DK1345907T3 (da) | 2006-11-13 |
| JP2004515541A (ja) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9903732A3 (en) | Use of cgmp elevators for the preparation of pharmaceutical compositions treating benign prostatic hyperplasia | |
| EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
| EA200200306A1 (ru) | Трициклические ингибиторы поли(адф-рибозо)полимераз | |
| IL101243A0 (en) | Pharmaceutical compositions for treatment of benign prostatic hyperplasia | |
| BG105811A (en) | Tricyclic inhibitors of poly(adp-ribose) polymerases | |
| CY1110589T1 (el) | ΠΑΡΑΓΩΓΑ ΤΗΣ ΘΕΙΕΝΟ(2,3-b)ΠΥΡΙΔΙΝΗΣ ΧΡΗΣΙΜΑ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ ΤΗΣ ΟΡΜΟΝΗΣ ΑΠΕΛΕΥΘΕΡΩΣΕΩΣ ΓΟΝΑΔΟΤΡΟΠΟΥ ΟΡΜΟΝΗΣ | |
| NZ234327A (en) | Quinazoline derivatives and pharmaceutical compositions | |
| BR9812122A (pt) | Combinação de inibidor da tirosina quinase e castração quìmica para tratar câncer da próstata | |
| HK1021699A1 (en) | Pentafluorobenzenesulfonamides and analogs. | |
| BG106116A (en) | 5-cyano-2-aminopyrimidine derivatives | |
| MXPA02001667A (es) | Composicion y metodo neuroterapeutico. | |
| RS105204A (en) | Substituted 3-amino-thieno/2,3-b/pyridine- 2-carboxylic acid amide compounds and processes for preparing and their uses | |
| ZA979961B (en) | 5-HT1F agonists | |
| IL146482A0 (en) | Tek antagonists | |
| MY136033A (en) | N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate | |
| TW270922B (es) | ||
| ATE355288T1 (de) | Verbindungen und therapeutische methoden | |
| IL151198A0 (en) | Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| ATE557007T1 (de) | Arylpyrimidine geeignet zur behandlung von sexualhormonbedingten zuständen wie endometriose, prostatakrebs und dergleichen | |
| DE69911017D1 (en) | Arylsulfonanilid-phosphate | |
| IL135634A0 (en) | 5-htif agonists | |
| WO2001030804A3 (en) | Salt form of a conjugate useful in the treatment of prostate cancer | |
| HUP0102805A2 (hu) | Tienopiridin-származékok, előállításuk és alkalmazásuk | |
| ATE297926T1 (de) | Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen | |
| HUP9901139A3 (en) | Use of melatonin agonists for producing pharmaceutical compositions suitable for treating benign prostatic hyperplasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20211210 |